Download Lymphoma Presentation and Diagnosis PowerPoint Presentation

Iframe embed code :

Unable to generate embed code for this presentation.request for embed code @ mail[at]slidesfinder.com

Presentation url :

Home / Health & Wellness / Health & Wellness Presentations / Lymphoma Presentation and Diagnosis PowerPoint Presentation

Lymphoma Presentation and Diagnosis PowerPoint Presentation

PowerPoint is the world's most popular presentation software which can let you create professional Lymphoma Presentation and Diagnosis powerpoint presentation easily and in no time. This helps you give your presentation on Lymphoma Presentation and Diagnosis in a conference, a school lecture, a business proposal, in a webinar and business and professional representations.

The uploader spent his/her valuable time to create this Lymphoma Presentation and Diagnosis powerpoint presentation slides, to share his/her useful content with the world. This ppt presentation uploaded by slidesfinder in Health & Wellness ppt presentation category is available for free download,and can be used according to your industries like finance, marketing, education, health and many more.

About This Presentation

slidesfinder

Description : Available Lymphoma Presentation and Diagnosis powerpoint presentation for free download which is uploaded by honey an active user in belonging ppt presentation Health & Wellness category.

Tags : Lymphoma Presentation and Diagnosis

Published on : Feb 24, 2014
Views : 1705 | Downloads : 3

Download Now

Share on Social Media

Slide 1 -

Lymphoma Presentation and Diagnosis Mark B. Juckett MD Division of Hematology University of Wisconsin June 19, 2003

Slide 2 -

Approach to Lymphadenopathy Palpable LAD in children – “the rule” LAD in adults < 1cm considered “normal” (< 2cm in groin) LAD is normal response to foreign antigens May include infections, allergens, autoimmune targets Pathologic LAD due to proliferation or infiltration

Slide 3 -

Normal B cell Development Travel

Slide 4 -

B cell finds “meaning” Germinal Center Formation

Slide 5 -

Germinal Center Activity

Slide 6 -

Plasma Cells travel back to bone marrow Plasmacytoid Cell IgM

Slide 7 -

Causes of LAD Infections Bacterial – pyogenic, cat-scratch, syphilis, tularemia, plague Mycobacterial – tuberculosis, leprosy, MAI Fungal – histoplasmosis, coccidioidiomycosis Chlamydial – lymphogranuloma venereum Parasitic – toxo, trypanosomiasis, filariasis Viral – EBV, CMV, rubella, HIV, hepatitis C

Slide 8 -

Causes of LAD (cont) Inflammatory disorders Autoimmune - Rheumatoid arthritis, SLE Drugs – serum sickness, phenytoin Castleman’s disease Histiocytic diseases (SHML, LH) Kawasaki syndrome Kimura’s disease Sarcoidosis

Slide 9 -

Causes of LAD (cont) Storage diseases Gaucher’s, Neimann-Pick disease Amyloidosis Endocrinopathies Hyperthyroidism, adrenal insufficiency Cancer “Immune system” cancers Metastatic carcinoma

Slide 10 -

Most Frequent Causes Unexplained (?) Infection Immune system disorders Immune system malignancies (Lymphoma) Metastatic carcinoma Other

Slide 11 -

Approach to patient with LAD Does the patient have a known illness that causes LAD? Treat and monitor Is there infection? Treat and monitor. Is the LAD large (> 3cm) or have unusual characteristic (i.e. hard)? Biopsy. If none are true, monitor 2 to 6 weeks, if persistent or large, biopsy.

Slide 12 -

Mortality Rate by Cancer1970 - 1994 Males Age 50 - 74

Slide 13 -

Mortality Rate by State1970 - 1994 NHL Males Age 50 - 74

Slide 14 -

Mortality Rate by Year1950 - 1994 NHL All ages

Slide 15 -

Incidence Rate by Year1973 - 2000 NHL All ages

Slide 16 -

Incidence Rate by Age1996 - 2000 NHL M/F

Slide 17 -

Classification of Lymphoma Past schemes: Rappaport, Kiel, Working formulation, “R.E.A.L.”, others World Health Organization involved to develop uniform classification Focus on defining distinct disease entities Classification defined 23 separate NHL and 5 Hodgkins lymphoma diagnoses.

Slide 18 -

General Comments on Diagnosis Initial diagnosis depends on tissue biopsy FNA rarely useful Fresh tissue important for path studies Flow cytometry and cytogenetics helpful Best imaging techniques: CT, PET scan Important labs: LDH, CBC Also LFT’s, Alb, Cr, uric acid, lytes

Slide 19 -

WHO Lymphoma Types Precursor B-lymphoblastic leukemia/lymphoma CLL / SLL Prolymphocytic leukemia Lymphoplasmacytic lymphoma Marginal zone B-cell lymphoma Hairy cell leuekmia Follicle center lymphoma Mantle cell lymphoma Diffuse large cell B-cell lymphoma Burkitt's lymphoma/Burkitt's cell leukemia Precursor T-lymphoblastic leukemia/lymphoma T cell prolymphocytic leukemia T-cell granular lymphocytic leukemia Aggressive NK-Cell leukemia Adult T cell lymphoma/leukemia Extranodal NK/T-cell nasal type Enteropathy-type T-cell lymphoma Hepatosplenic T-cell lymphoma Subcutaneous panniculitis-like T-cell Mycosis fungoides/Sézary's syndrome Anaplastic large cell lymphoma Peripheral T cell lymphoma Angioimmunoblastic T cell lymphoma

Slide 20 -

General Comments on Prognosis Many lymphomas are curable Even after relapse The incurable NHL can be indolent International Prognostic Index Most important for most NHL Age over 60 Stage 3 or 4 disease More than one extranodal site Elevated LDH Poor general health

Slide 21 -

Most Common NHL Diagnoses Diffuse Large B-cell Lymphoma Follicular Lymphoma Small Lymphocytic Lymphoma Mantle Cell Lymphoma Peripheral T-cell Lymphoma Armitage JCO 16:2780, 1998

Slide 22 -

Diffuse Large B-cell Lymphoma Present with symptoms from focal disease Most common lymphoma (30 – 40%) Aggressive behavior Median Age: 64 yo IPI predictive of response and survival Standard treatment: CHOP ± rituximab Curable with chemotherapy

Slide 23 -

Prognosis of DLCL by IPI NEJM 329:987, 1993

Slide 24 -

Follicular Lymphoma Asymptomatic LAD Median age: 59 yo Indolent behavior Median survival 10 years Stage III – IV disease 67% IPI predictive, few high risk Incurable with chemo Stage I curable with XRT Treatment based on symptoms No need to treat at diagnosis Characteristic t(14:18)

Slide 25 -

Small Lymphocytic Lymphoma Asymptomatic LAD Median Age 65 “Solid” counterpart to CLL Indolent behavior Median survival 4 – 5 years Stage III – IV disease 91% Incurable with chemo Treatment based on symptoms No need to treat at diagnosis Treatment as for CLL

Slide 26 -

Mantle Cell Lymphoma Few symptoms at diagnosis Indolent behavior at diagnosis Relentless progression Median survival 2 yrs Male predominance 3:1 Stage III – IV 80% GI/blood involvement common Poor overall response & survival Aggressive regimens may help Characteristic t(11:14)

Slide 27 -

Peripheral T-cell Lymphoma Present with symptoms from focal disease Aggressive behavior Median Age: 61 yo IPI not predictive of response and survival Survival short: median 1 year Standard treatment (?) CHOP Few are cured with chemotherapy Novel approaches needed

Slide 28 -

Treatment of NHL Most aggressive lymphomas CHOP – cyclophosphamide, vincristine, doxorubicin, and prednisone Most indolent lymphomas Many need no treatment – only for symptoms Oral alkylators, CVP, CHOP, fludarabine, rituximab (antibiotics for MALT) Relapse – many patients will benefit from high dose chemotherapy (transplant)

Slide 29 -

High-dose Chemotherapy with Stem Cell Rescue Philip et al NEJM 333:1540, 1995

Slide 30 -

Rituximab (Rituxan®) FDA Approved Indication “RITUXAN is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, CD20 positive B-cell non-Hodgkin’s lymphoma” IgG1 kappa chimeric murine/human monoclonal antibody against CD20 Application in B-cell malignancy and autoimmunity

Slide 31 -

Making Chimeric Antibody Murine Anti-CD20 Ig gene Human IgG1 gene Mouse Human Chimeric Gene Clone Variable Region gene Clone Constant Region gene Cellular Producer

Slide 32 -

Mechanisms of Activity for IgG1 Antibodies Complement Dendritic Cell NK Cell

Slide 33 -

New Agents/Approaches Rituximab Most commonly prescribed cancer drug Ibritumomab Tiuxetan (Zevalin®) Yittrium 90 labeled rituximab Iodine 131 Tositumomab (Bexxar®) Alemtuzumab (Campath 1H®) Pentostatin, Fludarabine, Cladribine

Slide 34 -

Conclusion Persistent LAD in older pts needs biopsy Many with aggressive lymphoma will be cured Many with indolent lymphoma will live many years with disease Our ability to define NHL has outpaced our knowledge of how to best treat Many new agents available (how to use?)

Frequently Asked Questions

> About SlidesFinder?

Slidesfinder is a website that allows users to upload and share their PowerPoint presentations online. It provides a platform for individuals and businesses to share their ideas and knowledge through presentations, and for others to view and download these presentations for educational or professional purposes.
Slidesfinder offers a wide range of presentation topics and categories, including business, education, science, technology, health, and more. Users can also search for presentations using keywords, tags, or by category. The website provides tools to create professional presentations with rich media, animations, and graphics.

One of the key features of Slidesfinder is its user-friendly interface, which allows users to easily upload, view, and share presentations. Users can also embed their presentations in their websites or blogs using the website's embed code feature.
Slidesfinder also offers premium services, such as the ability to create private presentations and to download presentations in high-quality formats. However, the basic features of Slidesfinder are free to use, making it accessible to anyone who wants to share their ideas and knowledge through presentations.

> How do I register with SlidesFinder?

Go to registration page (you can see signup link on top of website page) https://www.slidesfinder.com/signup . If you have facebook/gmail account them just click on SIGN IN WITH FACEBOOK OR SIGN IN WITH GOOGLE button, by this you will be a registered member of slidesfinder without filling any form, required detail automatically will be fatch from your account. If you do not a Facebook account, then click on "Signup". Fill all required fields and you will be a registered member of slidesfinder.

> Is slidesfinder account confirmation is mandatory?

Yes it is mandetory to active your account to login.

> Do I need to signup/login on SlidesFinder before uploading a PowerPoint presentation?

Yes, you need to login with your account before uploading presentation. Your username will be displayed on your uploaded presentation. Your registered email id is needed for sending your stats of uploaded presentation.

Slidesfinder is a sharing website for PowerPoint presentations search and share. Find your interest in the form of powerpoint presentations on slidesfinder and save your valuable time . On Slidesfinder you get presentations from our huge library of professional ppt presentations. We believe in making your search INFORMATIVE and FUN. Find your best ppt presentation from a pool of PowerPoint presentations stacked under important industry categories like business & management, heath & Wellness,eduction & training etc. We provide unique informative PowerPoint presentation for marketers, presenters and educationists. These professional PowerPoint presentations are uploaded by professionals from across numerous industry segments.These ppt presentations are available for FREE download.

Not just finding your interest, but facilitate you broadcast your interest. We have created this platform for easy sharing of PowerPoint presentations, ensuring that these presentations get maximum exposure. Create your slidesfinder account and upload PowerPoint presentations for free, share on social media platforms and BUILD YOUR CROWD WITH PRESENTATION !!

The Great Buddha says, "Share your knowledge.It’s a way to achieve immortality"! So, start sharing knowledge and we are here to make that immortal !!

Re-productivity of content are not allowed. Without prior written permission from author, commercial use of any content is illegal.